Brandon Reyneke

Dr. Brandon Reyneke

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2017 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
BRBrandon Reyneke
Brandon Reyneke
TNThando Ndlovu
Thando Ndlovu
SKS. Khan
S. Khan
WKWesaal Khan
Wesaal Khan

23 December 2019 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
BHBenjamin Havenga
Benjamin Havenga
TNThando Ndlovu
Thando Ndlovu
TCTanya Clements
Tanya Clements
BRBrandon Reyneke
Brandon Reyneke
MWMonique Waso
Monique Waso
WKWesaal Khan
Wesaal Khan
Background: The antimicrobial resistance of clinical, environmental and control strains of the WHO “Priority 1: Critical group” organisms, Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa to various classes of antibiotics, colistin and surfactin (biosurfactant) was determined. Methods: Acinetobacter baumannii was isolated from environmental samples and antibiotic resistance profiling was performed to classify the test organisms [A. baumannii (n = 6), P. aeruginosa (n = 5), E. coli (n = 7) and K. pneumoniae (n = 7)] as multidrug resistant (MDR) or extreme drug resistant (XDR). All the bacterial isolates (n = 25) were screened for colistin resistance and the mobilised colistin resistance (mcr) genes. Biosurfactants produced by Bacillus amyloliquefaciens ST34 were solvent extracted and characterised using ultra-performance liquid chromatography (UPLC) coupled to electrospray ionisation mass spectrometry (ESI–MS). The susceptibility of strains, exhibiting antibiotic and colistin resistance, to the crude surfactin extract (cell-free supernatant) was then determined. Results: Antibiotic resistance profiling classified four A. baumannii (67%), one K. pneumoniae (15%) and one P. aeruginosa (20%) isolate as XDR, with one E. coli (15%) and three K. pneumoniae (43%) strains classified as MDR. Many of the isolates [A. baumannii (25%), E. coli (80%), K. pneumoniae (100%) and P. aeruginosa (100%)] exhibited colistin resistance [minimum inhibitory concentrations (MICs) ≥ 4 mg/L]; however, only one E. coli strain isolated from a clinical environment harboured the mcr-1 gene. UPLC-MS analysis then indicated that the B. amyloliquefaciens ST34 produced C13–16 surfactin analogues, which were identified as Srf1 to Srf5. The crude surfactin extract (10.00 mg/mL) retained antimicrobial activity (100%) against the MDR, XDR and colistin resistant A. baumannii, P. aeruginosa, E. coli and K. pneumoniae strains. Conclusion: Clinical, environmental and control strains of A. baumannii, P. aeruginosa, E. coli and K. pneumoniae exhibiting MDR and XDR profiles and colistin resistance, were susceptible to surfactin analogues, confirming that this lipopeptide shows promise for application in clinical settings.

1 September 2018 in Journal of Environmental Quality
Verified
Journal Article
Closed access
PDF file
Kerry HamiltonKerry Hamilton
Kerry Hamilton
MWMonique Waso-Reyneke
Monique Waso-Reyneke
BRBrandon Reyneke
Brandon Reyneke
NSNazanin Saeidi
Nazanin Saeidi
ALAudrey Levine
Audrey Levine
WAWarish Ahmed
Warish Ahmed

1 May 2016 in Science of The Total Environment
Verified
Journal Article
Closed access
BRBrandon Reyneke
Brandon Reyneke
PDP.H. Dobrowsky
P.H. Dobrowsky
TNT. Ndlovu
T. Ndlovu
SKS. Khan
S. Khan
WKWesaal Khan
Wesaal Khan

1 May 2020 in Science of The Total Environment
Verified
Journal Article
Closed access
BRBrandon Reyneke
Brandon Reyneke
TNT. Ndlovu
T. Ndlovu
MVM.B. Vincent
M.B. Vincent
AMA. Martínez-García
A. Martínez-García
MPM.I. Polo-López
M.I. Polo-López
WKWesaal Khan
Wesaal Khan

9 December 2016 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
ASAndré Strauss
André Strauss
PDPenelope Heather Dobrowsky
Penelope Heather Dobrowsky
TNThando Ndlovu
Thando Ndlovu
BRBrandon Reyneke
Brandon Reyneke
WKWesaal Khan
Wesaal Khan
Numerous pathogens and opportunistic pathogens have been detected in harvested rainwater. Developing countries, in particular, require time- and cost-effective treatment strategies to improve the quality of this water source. The primary aim of the current study was thus to compare solar pasteurization (SOPAS; 70 to 79 °C; 80 to 89 °C; and ≥90 °C) to solar disinfection (SODIS; 6 and 8 hrs) for their efficiency in reducing the level of microbial contamination in harvested rainwater. The chemical quality (anions and cations) of the SOPAS and SODIS treated and untreated rainwater samples were also monitored. While the anion concentrations in all the samples were within drinking water guidelines, the concentrations of lead (Pb) and nickel (Ni) exceeded the guidelines in all the SOPAS samples. Additionally, the iron (Fe) concentrations in both the SODIS 6 and 8 hr samples were above the drinking water guidelines. A >99% reduction in Escherichia coli and heterotrophic bacteria counts was then obtained in the SOPAS and SODIS samples. Ethidium monoazide bromide quantitative polymerase chain reaction (EMA-qPCR) analysis revealed a 94.70% reduction in viable Legionella copy numbers in the SOPAS samples, while SODIS after 6 and 8 hrs yielded a 50.60% and 75.22% decrease, respectively. Similarly, a 99.61% reduction in viable Pseudomonas copy numbers was observed after SOPAS treatment, while SODIS after 6 and 8 hrs yielded a 47.27% and 58.31% decrease, respectively. While both the SOPAS and SODIS systems reduced the indicator counts to below the detection limit, EMA-qPCR analysis indicated that SOPAS treatment yielded a 2- and 3-log reduction in viable Legionella and Pseudomonas copy numbers, respectively. Additionally, SODIS after 8 hrs yielded a 2-log and 1-log reduction in Legionella and Pseudomonas copy numbers, respectively and could be considered as an alternative, cost-effective treatment method for harvested rainwater.